These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16790944)

  • 21. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
    Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
    J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications.
    Boschin IM; Torresan F; Toniato A; Zane M; Ide EC; Pennelli G; Rampin L; Colletti PM; Rubello D; Pelizzo MR
    Endocrine; 2014 Apr; 45(3):448-53. PubMed ID: 23884895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early therapeutic management of patients genetically predisposed to medullary thyroid cancer].
    Murat A; Modigliani E; Conte-Devolx B; Rohmer V; Leclerc L; Guilhem I; Bigorgne JC; Boneu A; Maes B; Chabre O; Niccoli P; Schuffenecker I; Giraud S
    Ann Chir; 1998; 52(5):455-60. PubMed ID: 9752487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment.
    Fugazzola L; Di Stefano M; Censi S; Repaci A; Colombo C; Grimaldi F; Magri F; Pagotto U; Iacobone M; Persani L; Mian C
    J Endocrinol Invest; 2021 Mar; 44(3):587-597. PubMed ID: 32656666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
    Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma.
    Kudo T; Miyauchi A; Ito Y; Yabuta T; Inoue H; Higashiyama T; Tomoda C; Hirokawa M; Amino N
    Endocr J; 2011; 58(3):217-21. PubMed ID: 21358115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels.
    Tisell LE; Dilley WG; Wells SA
    Surgery; 1996 Jan; 119(1):34-9. PubMed ID: 8560383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels.
    Fanget F; Demarchi MS; Maillard L; Lintis A; Decaussin M; Lifante JC
    Br J Surg; 2021 Sep; 108(9):1064-1071. PubMed ID: 33899100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature.
    Dora JM; Canalli MH; Capp C; Puñales MK; Vieira JG; Maia AL
    Thyroid; 2008 Aug; 18(8):895-9. PubMed ID: 18651801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative calcitonin study in medullary thyroid carcinoma.
    Ismailov SI; Piulatova NR
    Endocr Relat Cancer; 2004 Jun; 11(2):357-63. PubMed ID: 15163310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma.
    Algeciras-Schimnich A; Preissner CM; Theobald JP; Finseth MS; Grebe SK
    J Clin Endocrinol Metab; 2009 Mar; 94(3):861-8. PubMed ID: 19088163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
    Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
    Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.
    Karanikas G; Moameni A; Poetzi C; Zettinig G; Kaserer K; Bieglmayer C; Niederle B; Dudczak R; Pirich C
    J Clin Endocrinol Metab; 2004 Feb; 89(2):515-9. PubMed ID: 14764755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medullary thyroid cancer with undetectable serum calcitonin.
    Brutsaert EF; Gersten AJ; Tassler AB; Surks MI
    J Clin Endocrinol Metab; 2015 Feb; 100(2):337-41. PubMed ID: 25490273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.
    Verbeek HH; de Groot JWB; Sluiter WJ; Muller Kobold AC; van den Heuvel ER; Plukker JT; Links TP
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD010159. PubMed ID: 32176812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter.
    Ozgen AG; Hamulu F; Bayraktar F; Yilmaz C; Tüzün M; Yetkin E; Tunçyürek M; Kabalak T
    Thyroid; 1999 Jun; 9(6):579-82. PubMed ID: 10411120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
    Gómez-Camarero P; Ortiz-de Tena A; Borrego-Dorado I; Vázquez-Albertino RJ; Navarro-González E; Ruiz-Franco-Baux JV; Cuenca-Cuenca JI
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):261-6. PubMed ID: 23067528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.
    Yip DT; Hassan M; Pazaitou-Panayiotou K; Ruan DT; Gawande AA; Gaz RD; Moore FD; Hodin RA; Stephen AE; Sadow PM; Daniels GH; Randolph GW; Parangi S; Lubitz CC
    Surgery; 2011 Dec; 150(6):1168-77. PubMed ID: 22136837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
    Machens A; Schneyer U; Holzhausen HJ; Dralle H
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2029-34. PubMed ID: 15634717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.